Please login to the form below
13
Revenue 2017Bristol-Myers Squibb
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
Roche pulls EU Tecentriq/Avastin filing in kidney cancer
Bristol-Myers Squibb’s combination of PD-1 inhibitor Opdivo (nivolumab) and CTLA4 inhibitor Yervoy (ipilimumab) had been turned down by the CHMP earlier this year on the grounds that adding
AZ drug matched to cancer mutation passes phase 2 test
The first approvals for type-agnostic therapies have already been granted, with Merck/MSD’s Keytruda (pembrolizumab( and Bristol-Myers Squibb’s Opdivo (nivolumab) – both PD-1 checkpoint inhibitors – greenlighted for
FDA green lights BMS’ multiple myeloma combo
Bristol-Myers Squibb and AbbVie have gained a rapid FDA approval to broaden the use of multiple myeloma treatment Empliciti as part of new combined treatment regimen. ... tackle this relentless cancer, ”said Joseph Eid, senior vice president and head
US pricing plan slammed for imposing “foreign price controls”
Analysts suggest the companies most affected by this would be Regeneron, Amgen, Roche, Johnson &Johnson and Bristol-Myers Squibb, as they have the largest exposure to Medicare Part B.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager- Healthcare Advertising
-
Negotiable
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Business Director
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Business Development Director – Health Education
-
excellent commission
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Principal Health Economist - North-West
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Systematic Reviewer - Oxford
-
Negotiable
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial
- ‘No deal’ Brexit could see pharmacists take lead amid drug shortages
- Lilly partners with AC Immune on tau drug for Alzheimer’s
- Combined immunotherapies – potential and pitfalls
- Blue Latitude Health joins Fishawack Group of Companies
- Clark Health Communications to bring AI to the forefront with new deal
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
Quick links
Infographics
